Richmond Pharmacology ensures your regulatory submissions meet the requirements for global regulators.

Our experienced Advanced Research Science team will compile all necessary documentation, including writing the information for volunteers, informed consent form and completing the online IRAS application form. Richmond Pharmacology can obtain necessary documentation and specialist opinions for ethics submissions, in order to obtain approvals in a timely manner. We work closely with many ethics committees, local and nationwide, and will select an ethics committee based on study needs.

If required, the Principal Investigator will attend the ethics committee meeting to participate in discussions and ensure a smooth approval process.

As well as working with many Phase I ethics committees, we also work closely with our local ethics committee which approves Phase II studies. If required, we will obtain HRA approval for a specific NHS site, a process of which Richmond Pharmacology has extensive experience.

Richmond Pharmacology will also organise and oversee the CTA application to the MHRA if required. We have submitted numerous CTAs to the MHRA on behalf of our clients, typically gaining approval after the first review of the study documentation.

We ensure your regulatory submissions will fulfil the requirements of the FDA, MHRA, EMA and PMDA.

Get in touch today

Latest news

Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery

September 12, 2023
Discover how Richmond's dedicated team of volunteers is making a positive impact on young minds at Arc Nursery
Read more

Exciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors

September 5, 2023
We’re excited to share the findings of our recent study on the use of auto-injector systems (A-INJ) in randomized controlled trials (RCTs) by Dr Jorg Taubel, Dr Ulrike Lorch, Dr Thomas York and Vishal Aggarwal.
Read more

Events

BioJapan 2023

11-13 October 2023
BioJapan is "Asia's largest partnering event consisting of Exhibition, Seminar, and Partnering program".
View event